
MCOS-10
MRP: 1,090
Packaging: 10x10
Pack Type: tablet
Composition:
Lafutidine 10mg
Indication:
To treat Gastric Ulcers, Duodenal Ulcers, Gastric Mucosal Lesions, Associated with Gastritis
Description:
Lafutidine 10 mg is a potent histamine H2 receptor antagonist used primarily to reduce stomach acid production. It is commonly prescribed for treating gastric ulcers, duodenal ulcers, gastroesophageal reflux disease (GERD), and erosive gastritis. Lafutidine not only blocks acid secretion but also enhances mucosal defense by increasing mucus and bicarbonate secretion, providing a protective effect on the gastrointestinal lining. Its dual action helps in faster healing of ulcers and relief from acid-related symptoms such as heartburn and indigestion. Lafutidine is preferred for its effective acid suppression with a good safety profile.
Tags:
- Reduces gastric acid secretion effectively
- Promotes healing of gastric and duodenal ulcers
- Provides relief from heartburn and acid reflux symptoms
- Enhances gastric mucosal defense mechanisms
- Well tolerated with a low incidence of side effects
- Improves quality of life in acid-related gastrointestinal disorders
Usage Information
Dosage
Typical adult dose: 10 mg once or twice daily as prescribed Take orally, preferably before meals Swallow tablets whole with water Follow the treatment duration advised by your healthcare provider
Side Effects
Headache Dizziness Diarrhea or constipation Nausea Skin rash or itching (rare) Fatigue Most side effects are mild and transient. Consult a doctor if severe reactions occur.
Contraindications
Hypersensitivity to Lafutidine or other H2 receptor antagonists Severe liver or kidney impairment without medical supervision Pregnant or breastfeeding women unless prescribed Concurrent use with drugs that may interact and increase side effects should be monitored
Availability
Lafutidine 10 mg tablets, H2 receptor antagonist, gastric ulcer treatment, GERD medication, acid reflux relief, stomach acid reducer, lafutidine benefits, lafutidine dosage
